Kodiak Gas Services, Inc. (KGS)

Augmedix Stock Forecast

Stock Price Forecast

The 10 analysts that cover Augmedix stock have a consensus rating of "Strong Buy" and an average price target of $41.2, which forecasts a 31.63% increase in the stock price over the next year. The lowest target is $35 and the highest is $48.

Price Target: $41.20 (+31.63%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$35	$41.2	$43	$48
Change	+11.82%	+31.63%	+37.38%	+53.35%

* Price targets were last updated on Jun 23, 2025.

Analyst Ratings

The average analyst rating for Augmedix stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Feb '25	Mar '25	Apr '25	May '25	Jun '25	Jul '25
Strong Buy	5	5	5	5	6	6
Buy	4	4	4	4	3	3
Hold	2	2	2	2	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	11	11	11	11	10	10

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jeremy Tonet JP Morgan	JP Morgan	Hold → Strong Buy Initiates $42 → $43	Hold → Strong Buy	Initiates	$42 → $43	+37.38%	Jun 23, 2025
Gabriel Moreen Mizuho	Mizuho	Buy Maintains $46 → $45	Buy	Maintains	$46 → $45	+43.77%	May 20, 2025
Theresa Chen Barclays	Barclays	Hold Maintains $41 → $36	Hold	Maintains	$41 → $36	+15.02%	Apr 16, 2025
Gabriel Moreen Mizuho	Mizuho	Buy Maintains $55 → $46	Buy	Maintains	$55 → $46	+46.96%	Apr 11, 2025
Theresa Chen Barclays	Barclays	Hold Maintains $44 → $41	Hold	Maintains	$44 → $41	+30.99%	Mar 21, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

1.36B

Increased by 16.97%

from 1.16B

Revenue Next Year

1.44B

Increased by 6.27%

from 1.36B

EPS This Year

1.76

Increased by 210.96%

from 0.56

EPS Next Year

2.16

Increased by 23.17%

from 1.76

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	532.42M	606.38M	707.91M	850.38M	1.16B	1.36B	1.44B	1.52B
Revenue Growth	-	13.89%	16.74%	20.13%	36.33%	16.97%	6.27%	5.69%
EPS	-	3.07	1.80	0.29	0.56	1.76	2.16	2.59
EPS Growth	-	-	-41.31%	-83.89%	94.67%	210.96%	23.17%	19.72%
Forward PE	-	-	-	-	-	17.83	14.48	12.09
No. Analysts	-	-	-	-	-	10	9	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	1.4B	1.5B	1.7B
Avg	1.4B	1.4B	1.5B
Low	1.3B	1.4B	1.4B

Revenue Growth

Revenue Growth	2025	2026	2027
High	23.3%	13.3%	17.8%
Avg	17.0%	6.3%	5.7%
Low	11.8%	0.2%	-2.5%

EPS Forecast

EPS	2025	2026	2027
High	2.25	2.55	3.06
Avg	1.76	2.16	2.59
Low	1.41	1.73	2.01

EPS Growth

EPS Growth	2025	2026	2027
High	298.0%	45.3%	41.3%
Avg	211.0%	23.2%	19.7%
Low	150.0%	-1.2%	-7.1%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.